More details of Chris Froome's successful salbutamol defence

Chris Froome celebrates sealing the overall win after stage 20 at the Giro

Although Team Sky said it would not be releasing the details of the evidence that led to Chris Froome being absolved of an anti-doping rule violation for excess levels of salbutamol in the 2017 Vuelta a Espana, Froome himself gave further information in an interview with The Times , refuting the oft-stated assertion that his sample tested at twice the allowed limit. "The most frustrating part was when I'd see stuff that was totally incorrect but supposedly leaked. Because then everyone would assume it was a fact," Froome told The Times ' Matt Dickinson. He went on to confirm that his sample was adjusted for dehydration, which was not part of the standard procedure for doping control analysis until this year. Froome's uncorrected salbutamol level was 2000ng/mL, as reported last year in the original story published by The Guardian and Le Monde on December 13. That value is double WADA's ...

Read on Cycling News


More Like This

Card image cap

UCI says no reasoned decision will be released for Froome case, elaborates on related topics

View
Card image cap

Analysis: WADA appears to contradict UCI over Froome case decision

View
Card image cap

WADA deny giving Chris Froome a legal loophole by avoiding pharmacokinetic study

View
Card image cap

WADA will not appeal UCI verdict on Chris Froome salbutamol case

View
Card image cap

Research paper raises questions about Salbutamol tests, may aid Froome’s defence

View
Card image cap

What the newest salbutamol study means for Froome

View
Card image cap

Petacchi feels vindicated by resolution of Chris Froome case

View
Card image cap

Opinion: Why WADA and the UCI’s handling of the Froome case is damaging to sport

View
Card image cap

UCI responds to criticism surrounding Chris Froome judgement

View
Card image cap

WADA decides against Froome anti-doping appeal

View